Through gene coexpression analysis, we revealed a coexpression relationship between the histone H3-3B gene and the CD44 and HIF1A molecules, and revealed that histone acetylation and deacetylation scores are increased in IBC tumour cells, which suggests that targeting the acetylation regulation of histones may be a potential therapeutic strategy. This evidence concerns the gene HIF1A and neoplasm.